NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . May 4th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Alkermes, Inc. - Alkermes Completes Enrollment for Registration Study of VIVITROL® in Patients with Opioid Dependence

Hepatitis C Virus - Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients

Impax Laboratories, Inc. - Impax Pharmaceuticals Reports Positive Achievements on its Two Leading Brand Product Candidates IPX066 and IPX056

Pharmaceuticals - NovaBay(R) Pharmaceuticals Enters into Agreement to Broaden Intellectual Property Estate and Expand Clinical Opportunities for Its Aganocide(R) Compounds

Angiogenesis - Reports from S.M. Gressett and co-researchers add new data to research in angiogenesis

Breast Cancer - Reports from J.R. Infante and colleagues advance knowledge in breast cancer

Breast Cancer - Researchers from Northwestern University publish new studies and findings in the area of breast cancer

Breast Cancer - Study findings on breast cancer are outlined in reports from C.D. Britten and colleagues

Chronic Lymphocytic Leukemia - Data on chronic lymphocytic leukemia published by researchers at Ohio State University

Drug Resistance - Study results from J. Mebis et al provide new insights into drug resistance

Heart Failure - New heart failure research from GE Healthcare outlined

Life Sciences - Recent findings from West Virginia University highlight research in life sciences

Obesity - Research data from A. Bryson and colleagues update understanding of obesity

Pandemics - New findings from J. Wu and co-authors in the area of pandemics published

Pharmacokinetics - Research on pharmacokinetics discussed by G. Krishna and co-researchers

Pulmonary Embolism - Studies from U. Tebbe and colleagues reveal new findings on pulmonary embolism

Stuttering - Scientists at University of Colorado report research in stuttering

Tuberculosis - Researchers at Johns Hopkins University have published new data on tuberculosis

Vascular Endothelial Growth Factor - Research conducted by E.E.W. Cohen and co-researchers has updated our knowledge about vascular endothelial growth factor

Cancer Clinical Trial - Reports from Wayne State University, Karmanos Cancer Institute highlight recent research in cancer clinical trial

Cancer Therapy - New findings in cancer therapy described by M.G. Dodds and co-researchers

Chronic Lymphocytic Leukemia Therapy - Reports from Mayo Clinic highlight recent research in chronic lymphocytic leukemia therapy

Clinical Trial Research - New clinical trial research study findings have been reported from Mayo Clinic

Clinical Trial Research - New clinical trial research study findings recently were published by researchers at University of Chicago, Department of Health

Clinical Trial Research - New findings reported from Merck & Company, Inc. describe advances in clinical trial research

Clinical Trial Research - Study results from Novartis update understanding of clinical trial research

Colon Cancer Therapy - Research reports from J. Bennouna and co-authors provide new insights into colon cancer therapy

Colon Cancer Therapy - Researchers from Tokai University, Department of Surgery provide details of new studies and findings in the area of colon cancer therapy

Experimental Therapies - New experimental therapies study findings recently were reported by researchers at Duke University

Gastric Cancer Therapy - Studies conducted at University of Tokyo, Department of Surgical Oncology on gastric cancer therapy recently published

Gastrointestinal Stromal Tumors Therapy - New findings from Asan Medical Center, Department of Internal Medicine in the area of gastrointestinal stromal tumors therapy described

HIV/AIDS Therapy - New HIV/AIDS therapy research from F. Tomaka et al outlined

Menorrhagia Therapy - New menorrhagia therapy study findings recently were reported by researchers at Seoul National University

Quality of Life - Aarhus University, Department of Oncology publishes research in quality of life

Advaxis, Inc - Advaxis in Drug Licensing Discussions for Its Flagship Vaccine Construct, ADXS11-001

Allergies - Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

Alzheimer Disease - FDA Gives Clinical Trial Green Light on Drug to Treat Alzheimer's Disease

Ardea Biosciences, Inc. - Ardea Biosciences Announces Positive Results from a Phase 1 Study of Lead Hyperuricemia and Gout Candidate, RDEA594 and a Phase 2a Study of RDEA594’s Prodrug, RDEA806

ARIAD Pharmaceuticals, Inc. - Preclinical Data Presented on ARIAD’s Investigational mTOR Inhibitor, Deforolimus, in Lung Cancer and Other Solid Tumor Models

Asthma - Amira Initiates Phase I Clinical Trial of Novel DP2 Antagonist

BioCom Partners - Peregrine's PS-targeting antibodies highlighted in AACR Annual Meeting studies

Bone Research - BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio a Syndrome

Breast Cancer - Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference

Bronchiectasis - Transave Completes Enrollment in Arikace(TM) Phase II Bronchiectasis Study

Can-Fite BioPharma - Can-Fite BioPharma to Initiate Phase I/II Clinical Trial With CF102 for the Treatment of Liver Cancer

Cancer - AcelRx Announces Initiation of Phase 2 Cancer Breakthrough Pain Program

Cancer - Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer

Cancer Vaccines - Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer

Chronic Hepatitis - Valeant Pharmaceuticals Highlights Taribavirin Phase IIb 60-Week Data Presentation at European Association for the Study of Liver (EASL) Annual Meeting

Colon Cancer - Celator(R) Pharmaceuticals Presents New Data on CPX-351 and CPX-1 at the American Association for Cancer Research

Colon Cancer - Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Picoplatin in Patients with Metastatic Colorectal Cancer

Exelixis, Inc. - Seven Abstracts Featuring Exelixis Compounds to Be Presented at 2009 ASCO Annual Meeting

Hadasit Bio Holdings - HBL Portfolio Company Tolarex to Commence Phase I/IIa Trial of a Treatment for GVHD

Hepatitis C Virus - ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients

Hepatitis C Virus - Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymerase Inhibitor in Development for Chronic Hepatitis C

Innate Therapeutics Limited - Virionyx Changes Name to Innate Therapeutics, Advances Novel Immune Stimulant, MIS416, to Clinical Trials

Lung Cancer - Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial

Lymphoma - AEterna Zentaris Presents Phase 1 Results for AEZS-112 in Patients with Advanced Cancer and Lymphoma at AACR Annual Meeting in Denver

Lymphoma - Medarex Announces Clinical Data for MDX-1401 in Hodgkin's Lymphoma at Annual Meeting of the American Association for Cancer Research

Malaria Vaccines - Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin

Mental Health - Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication

Myeloma - New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers

NanoBio Corp. - NanoBio Initiates FDA Approved Clinical Trial for Adjuvanted Intranasal Influenza Vaccine

NeuroScience Pharmaceuticals Inc. - NeuroScience Pharmaceuticals Launches in Research Triangle Park

Ohio State University Medical Center - Targeted agent shows promise in biliary cancer study

Pharmacokinetics - NKTR-105 Demonstrates Superior Antitumor Activity and Improved Pharmacokinetics Over Docetaxel in Preclinical Studies Presented at AACR

Pharmacyclics, Inc. - Pharmacyclics Updates Positive Clinical Responses in its PCI-24781 Clinical Program Targeting HDAC

Pro-Pharmaceuticals, Inc. - Pro-Pharmaceuticals’ DAVANAT® Prevents Mucositis, a Serious Side Effect of Chemotherapy, in All 100 Cancer Patients Treated

Research and Markets - Comprehensive Company Profiles of the Top 20 Contract Research Organisations In Europe for Ophthalmic Diseases & Disorders

Resolvyx Pharmaceuticals - Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer

Stanford University Medical Center - Stanford Study of Malaria Vaccine Needs Participants

Stem Cell Research - SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production

Syntagon - Syntagon to Supply Clinical Material for Parkinson’s, Huntington’s Research

Tinea Pedis - TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot

Type 2 Diabetes - Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes

Vertex Pharmaceuticals Incorporated - Vertex Pharmaceuticals Reviews First Quarter Business Progress and Reports First Quarter 2009 Financial Results

WFD Ventures - OptiNose presents new data on highly effective treatment for chronic rhinosinusitis



Return to Top of Page

-----------------------
PR Login